710 filings
Page 9 of 36
DEFA14A
c8b0h9u0
11 Mar 21
Additional proxy soliciting materials
5:25pm
8-K
bjfj78g0
11 Mar 21
Onconova Therapeutics Reports Full Year 2020 Financial Results, Provides Business Update
4:33pm
DEFA14A
c1xqv1
8 Mar 21
Additional proxy soliciting materials
5:20pm
DEFA14A
np8ms5r s06kwenur
4 Mar 21
Additional proxy soliciting materials
4:55pm
8-K/A
36g7basl6vlj4f2 hyj
4 Mar 21
Submission of Matters to a Vote of Security Holders
4:52pm
8-K
xwhh2ann ipnj0
4 Mar 21
Submission of Matters to a Vote of Security Holders
9:21am
DEFA14A
zva4548t5dm pz17i
26 Feb 21
Additional proxy soliciting materials
5:20pm
8-K
n6bchlnxevp8nzn hsq4
24 Feb 21
Other Events
8:05am
4
mfnu5 6sp0
19 Feb 21
Onconova Therapeutics / ABRAHAM N. OLER ownership change
5:29pm
4
ysdz6sk
19 Feb 21
Onconova Therapeutics / Mark Patrick Guerin ownership change
5:26pm
4
sw74f 1q6m
19 Feb 21
Onconova Therapeutics / Steven M Fruchtman ownership change
5:25pm
8-K
x6130mk3x28m
19 Feb 21
Departure of Directors or Certain Officers
5:19pm
DEFA14A
l0laj11neaqr
19 Feb 21
Additional proxy soliciting materials
5:18pm
4
jdrebx64qbovdkm8d
17 Feb 21
Onconova Therapeutics / ABRAHAM N. OLER ownership change
8:57am
4
dzgsc1
17 Feb 21
Onconova Therapeutics / Mark Patrick Guerin ownership change
8:55am
4
8dc4xdo2exgko2d
17 Feb 21
Onconova Therapeutics / Steven M Fruchtman ownership change
8:48am
4
5j66ypb8yl3qa4ztz
17 Feb 21
Onconova Therapeutics / JAMES J MARINO ownership change
8:46am
4
32pvm19552ukb6l1b5n
17 Feb 21
Onconova Therapeutics / Mary Teresa Shoemaker ownership change
8:45am
8-K
bo9ke6d ffaesqgzd780
16 Feb 21
Onconova Therapeutics, Inc. Announces Closing of $28.75 Million Public Offering of Common Stock Including Full Exercise of the Over-Allotment Option
4:08pm
8-K
keqqkba1
12 Feb 21
Onconova Therapeutics, Inc. Announces Pricing of $25 Million Public Offering of Common Stock
12:00am